GTHX NASDAQ
G1 Therapeutics, Inc.
1W: +0.3%
1M: +0.8%
3M: +179.3%
1Y: +379.9%
3Y: -48.7%
5Y: -80.3%
$7.16
Last traded 2024-09-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$58M
Revenue
-34.7% YoY
$-45M
Net Income
+45.9% YoY
$-38M
Free Cash Flow
+43.8% YoY
95.6%
Gross Margin
-21.4%
Op. Margin
-33.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-109.0%
ROA-36.3%
ROIC-254.4%
Valuation
P/E-7.7
P/B10.5
EV/EBITDA-3.2
Leverage
Debt/Equity1.95
Current Ratio2.48
Interest Cov.-3.8x
Quality Scores
Piotroski F3/9
Altman Z-10.19
Beneish M-2.24